News

Shaky healthcare claims in the GOP debate in Iowa (Morning Read)

Current medical news from today, including fact-checkers question the accuracy of healthcare statements made by GOP candidates in debate, video games and healthcare, and FDA to begin new certification program for medical device reviewers.

Current medical news and unique business news for anyone who cares about healthcare.

Shaky healthcare claims in Wednesday’s GOP debate. Fact-checking news site PolitiFact says most of the points made about healthcare in last night’s GOP debate were at least a little fudged. This included Michele Bachmann’s claim that the Congressional Budget Office said Obamacare will kill 800,000 jobs, Mitt Romney’s claim that his healthcare bill affected 8 percent of Massachusetts residents while Obamacare affected them all, and Gov. Rick Perry’s statement that his executive order requiring girls in sixth grade or older to be vaccinated for HPV included an “opt out” process.

An unlikely duo: video games and healthcare. Healthcare professionals are beginning to really acknowledge the influence of video games in healthcare. A new journal called Games for Health: Research, Development, and Clinical Applications and a companion newsletter will appear in the fall, and healthcare institutions are reporting use of the Wii and Kinect systems for illness detection and recovery.

Quicker device approval (hopefully). This month, the FDA will launch its agency-wide requirement of certification program to reduce the time it takes for a medical device to be reviewed.

Danish tech a good match for U.S.? One analyst is suggesting the U.S. look to investing in life science technology coming out of Denmark to provide the U.S. the innovation needed to improve our economic condition.

Study shows fanciest technology isn’t always best. An FDA-approved implantable medical device for stroke prevention — owned by Stryker and modeled after a heart stent — actually increase stroke risk over traditional drug and lifestyle treatment, according to a post-approval study.

Topics